PDB Short entry for 3CS9 HEADER TRANSFERASE 09-APR-08 3CS9 TITLE HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 229-500); COMPND 5 SYNONYM: P150, C-ABL, ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG COMPND 6 1; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS KEYWDS NILOTINIB, AMN107, KINASE, ABL, ALTERNATIVE SPLICING, ATP-BINDING, KEYWDS 2 CELL ADHESION, CHROMOSOMAL REARRANGEMENT, CYTOPLASM, CYTOSKELETON, KEYWDS 3 LIPOPROTEIN, MAGNESIUM, MANGANESE, METAL-BINDING, MYRISTATE, KEYWDS 4 NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, PROTO- KEYWDS 5 ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KEYWDS 6 KINASE, ABL KINASE WT IN COMPLEX WITH NVP-AMN107 EXPDTA X-RAY DIFFRACTION AUTHOR S.W.COWAN-JACOB,G.FENDRICH,P.MANLEY,J.LIEBETANZ,D.FABBRO REVDAT 4 03-APR-24 3CS9 1 REMARK REVDAT 3 21-FEB-24 3CS9 1 REMARK SEQADV REVDAT 2 24-FEB-09 3CS9 1 VERSN REVDAT 1 22-APR-08 3CS9 0 JRNL AUTH E.WEISBERG,P.W.MANLEY,W.BREITENSTEIN,J.BRUEGGEN, JRNL AUTH 2 S.W.COWAN-JACOB,A.RAY,B.HUNTLY,D.FABBRO,G.FENDRICH, JRNL AUTH 3 E.HALL-MEYERS,A.L.KUNG,J.MESTAN,G.Q.DALEY,L.CALLAHAN, JRNL AUTH 4 L.CATLEY,C.CAVAZZA,M.AZAM,D.NEUBERG,R.D.WRIGHT, JRNL AUTH 5 D.G.GILLILAND,J.D.GRIFFIN JRNL TITL CHARACTERIZATION OF AMN107, A SELECTIVE INHIBITOR OF NATIVE JRNL TITL 2 AND MUTANT BCR-ABL JRNL REF CANCER CELL V. 7 129 2005 JRNL REFN ISSN 1535-6108 JRNL PMID 15710326 JRNL DOI 10.1016/J.CCR.2005.01.007 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.VAJPAI,A.STRAUSS,G.FENDRICH,S.W.COWAN-JACOB,P.W.MANLEY, REMARK 1 AUTH 2 S.GRZESIEK,W.JAHNKE REMARK 1 TITL SOLUTION CONFORMATIONS AND DYNAMICS OF ABL KINASE INHIBITOR REMARK 1 TITL 2 COMPLEXES DETERMINED BY NMR SUBSTANTIATE THE DIFFERENT REMARK 1 TITL 3 BINDING MODES OF IMATINIB/NILOTINIB AND DASATINIB REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 65406 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3477 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4633 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 268 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8262 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 156 REMARK 3 SOLVENT ATOMS : 266 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.58000 REMARK 3 B33 (A**2) : -0.59000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.237 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.199 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.143 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.228 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8659 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 7677 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11732 ; 1.594 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17844 ; 1.035 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1003 ; 6.544 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 396 ;38.392 ;24.116 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1483 ;15.245 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 41 ;15.827 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1230 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9477 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1836 ; 0.010 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1855 ; 0.215 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 7523 ; 0.190 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 4422 ; 0.092 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 334 ; 0.170 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 39 ; 0.233 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 94 ; 0.256 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.240 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5548 ; 1.217 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2054 ; 0.236 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8165 ; 1.664 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4208 ; 2.297 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3567 ; 3.245 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3CS9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047150. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00033 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68942 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.530 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.25 REMARK 200 R MERGE FOR SHELL (I) : 0.40100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: UNPUBLISHED STRUCTURE OF ABL COMPLEX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10.5 % PEG 5000 MME, 0.1 M MES PH 5.5, REMARK 280 0.05 AMMONIUM ACETATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 46.96300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.84150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.04400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.84150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.96300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.04400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 224 REMARK 465 ALA A 225 REMARK 465 MET A 226 REMARK 465 ASP A 227 REMARK 465 PRO A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLU A 275 REMARK 465 ASP A 276 REMARK 465 THR A 277 REMARK 465 MET A 278 REMARK 465 GLY B 224 REMARK 465 ALA B 225 REMARK 465 MET B 226 REMARK 465 ASP B 227 REMARK 465 PRO B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 LEU B 384 REMARK 465 SER B 385 REMARK 465 ARG B 386 REMARK 465 LEU B 387 REMARK 465 MET B 388 REMARK 465 THR B 389 REMARK 465 GLY B 390 REMARK 465 ASP B 391 REMARK 465 THR B 392 REMARK 465 TYR B 393 REMARK 465 THR B 394 REMARK 465 ALA B 395 REMARK 465 HIS B 396 REMARK 465 ALA B 397 REMARK 465 GLY B 398 REMARK 465 ALA B 399 REMARK 465 LYS B 400 REMARK 465 PHE B 401 REMARK 465 GLY C 224 REMARK 465 ALA C 225 REMARK 465 MET C 226 REMARK 465 ASP C 227 REMARK 465 PRO C 228 REMARK 465 SER C 229 REMARK 465 PRO C 230 REMARK 465 ASN C 231 REMARK 465 LYS C 274 REMARK 465 GLU C 275 REMARK 465 ASP C 276 REMARK 465 THR C 277 REMARK 465 MET C 278 REMARK 465 LEU C 384 REMARK 465 SER C 385 REMARK 465 ARG C 386 REMARK 465 LEU C 387 REMARK 465 MET C 388 REMARK 465 THR C 389 REMARK 465 GLY C 390 REMARK 465 ASP C 391 REMARK 465 THR C 392 REMARK 465 TYR C 393 REMARK 465 THR C 394 REMARK 465 ALA C 395 REMARK 465 HIS C 396 REMARK 465 ALA C 397 REMARK 465 GLY C 398 REMARK 465 ALA C 399 REMARK 465 LYS C 400 REMARK 465 PHE C 401 REMARK 465 GLN C 498 REMARK 465 GLU C 499 REMARK 465 SER C 500 REMARK 465 GLY D 224 REMARK 465 ALA D 225 REMARK 465 MET D 226 REMARK 465 ASP D 227 REMARK 465 PRO D 228 REMARK 465 SER D 229 REMARK 465 PRO D 230 REMARK 465 ASN D 231 REMARK 465 TYR D 232 REMARK 465 LYS D 262 REMARK 465 LYS D 263 REMARK 465 TYR D 264 REMARK 465 SER D 265 REMARK 465 LEU D 266 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLU A 494 CD OE1 OE2 REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 GLU B 462 CD OE1 OE2 REMARK 470 GLU C 409 CG CD OE1 OE2 REMARK 470 GLU C 450 CG CD OE1 OE2 REMARK 470 GLU C 453 CG CD OE1 OE2 REMARK 470 GLU D 281 CD OE1 OE2 REMARK 470 GLU D 308 CG CD OE1 OE2 REMARK 470 LYS D 356 CG CD CE NZ REMARK 470 ASN D 374 CG OD1 ND2 REMARK 470 ARG D 386 CD NE CZ NH1 NH2 REMARK 470 LYS D 400 CD CE NZ REMARK 470 GLU D 453 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 662 O HOH A 695 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 325 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 421 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG A 473 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 ASP B 363 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 LEU B 471 CA - CB - CG ANGL. DEV. = 15.3 DEGREES REMARK 500 ARG B 473 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 473 NE - CZ - NH2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP D 325 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP D 455 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -143.61 -117.52 REMARK 500 SER A 265 46.77 35.38 REMARK 500 ARG A 362 -14.51 83.05 REMARK 500 ASP A 363 52.37 -147.28 REMARK 500 ALA A 399 -156.41 -136.01 REMARK 500 LYS B 245 -155.69 -93.14 REMARK 500 SER B 265 65.30 38.44 REMARK 500 ASN B 336 -168.63 -102.79 REMARK 500 ARG B 362 -12.94 81.36 REMARK 500 ALA B 365 158.12 179.12 REMARK 500 HIS B 375 34.64 70.50 REMARK 500 LYS C 245 -77.38 -105.65 REMARK 500 THR C 272 -168.46 -129.16 REMARK 500 ARG C 362 -13.85 81.89 REMARK 500 ASP C 363 43.40 -146.25 REMARK 500 TYR C 440 64.70 31.99 REMARK 500 LYS D 245 -128.42 -87.83 REMARK 500 GLU D 255 57.91 -63.92 REMARK 500 ASP D 276 76.48 -108.97 REMARK 500 HIS D 295 144.65 -172.32 REMARK 500 THR D 306 62.19 -115.41 REMARK 500 ARG D 307 -19.79 -149.47 REMARK 500 ARG D 362 -14.07 79.28 REMARK 500 ASP D 363 52.13 -146.17 REMARK 500 TYR D 440 55.24 37.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NIL A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NIL B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NIL C 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NIL D 600 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HYY RELATED DB: PDB REMARK 900 ABL KINASE IN COMPLEX WITH IMATINIB DBREF 3CS9 A 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 3CS9 B 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 3CS9 C 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 3CS9 D 229 500 UNP P00519 ABL1_HUMAN 229 500 SEQADV 3CS9 GLY A 224 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ALA A 225 UNP P00519 EXPRESSION TAG SEQADV 3CS9 MET A 226 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ASP A 227 UNP P00519 EXPRESSION TAG SEQADV 3CS9 PRO A 228 UNP P00519 EXPRESSION TAG SEQADV 3CS9 GLY B 224 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ALA B 225 UNP P00519 EXPRESSION TAG SEQADV 3CS9 MET B 226 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ASP B 227 UNP P00519 EXPRESSION TAG SEQADV 3CS9 PRO B 228 UNP P00519 EXPRESSION TAG SEQADV 3CS9 GLY C 224 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ALA C 225 UNP P00519 EXPRESSION TAG SEQADV 3CS9 MET C 226 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ASP C 227 UNP P00519 EXPRESSION TAG SEQADV 3CS9 PRO C 228 UNP P00519 EXPRESSION TAG SEQADV 3CS9 GLY D 224 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ALA D 225 UNP P00519 EXPRESSION TAG SEQADV 3CS9 MET D 226 UNP P00519 EXPRESSION TAG SEQADV 3CS9 ASP D 227 UNP P00519 EXPRESSION TAG SEQADV 3CS9 PRO D 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 A 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 A 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 A 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 A 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 A 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 A 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 A 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 A 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 A 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 A 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 A 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 A 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 A 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 A 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 A 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 A 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 A 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 A 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 A 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 A 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 A 277 PHE GLN GLU SER SEQRES 1 B 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 B 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 B 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 B 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 B 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 B 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 B 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 B 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 B 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 B 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 B 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 B 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 B 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 B 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 B 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 B 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 B 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 B 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 B 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 B 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 B 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 B 277 PHE GLN GLU SER SEQRES 1 C 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 C 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 C 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 C 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 C 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 C 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 C 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 C 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 C 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 C 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 C 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 C 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 C 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 C 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 C 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 C 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 C 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 C 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 C 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 C 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 C 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 C 277 PHE GLN GLU SER SEQRES 1 D 277 GLY ALA MET ASP PRO SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 D 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 D 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 D 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 D 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 D 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 D 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 D 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 D 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 D 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 D 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 D 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 D 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 D 277 TYR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 D 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 D 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 D 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 D 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 D 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 D 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 D 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 D 277 PHE GLN GLU SER HET NIL A 600 39 HET NIL B 600 39 HET NIL C 600 39 HET NIL D 600 39 HETNAM NIL NILOTINIB HETSYN NIL 4-METHYL-N-[3-(4-METHYL-1H-IMIDAZOL-1-YL)-5- HETSYN 2 NIL (TRIFLUOROMETHYL)PHENYL]-3-[(4-PYRIDIN-3-YLPYRIMIDIN- HETSYN 3 NIL 2-YL)AMINO]BENZAMIDE FORMUL 5 NIL 4(C28 H22 F3 N7 O) FORMUL 9 HOH *266(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 GLY A 249 GLN A 252 5 4 HELIX 3 3 LYS A 263 SER A 265 5 3 HELIX 4 4 GLU A 279 GLU A 292 1 14 HELIX 5 5 LEU A 323 CYS A 330 1 8 HELIX 6 6 ASN A 336 LYS A 357 1 22 HELIX 7 7 ALA A 365 ARG A 367 5 3 HELIX 8 8 GLU A 373 HIS A 375 5 3 HELIX 9 9 GLY A 383 LEU A 387 5 5 HELIX 10 10 PRO A 402 THR A 406 5 5 HELIX 11 11 ALA A 407 ASN A 414 1 8 HELIX 12 12 SER A 417 THR A 434 1 18 HELIX 13 13 ASP A 444 SER A 446 5 3 HELIX 14 14 GLN A 447 LYS A 454 1 8 HELIX 15 15 PRO A 465 TRP A 476 1 12 HELIX 16 16 ASN A 479 ARG A 483 5 5 HELIX 17 17 SER A 485 GLU A 499 1 15 HELIX 18 18 GLU B 238 THR B 240 5 3 HELIX 19 19 GLY B 249 GLN B 252 5 4 HELIX 20 20 GLU B 279 ILE B 293 1 15 HELIX 21 21 ASN B 322 CYS B 330 1 9 HELIX 22 22 ASN B 336 LYS B 357 1 22 HELIX 23 23 ALA B 365 ARG B 367 5 3 HELIX 24 24 GLU B 373 HIS B 375 5 3 HELIX 25 25 PRO B 402 THR B 406 5 5 HELIX 26 26 ALA B 407 ASN B 414 1 8 HELIX 27 27 SER B 417 THR B 434 1 18 HELIX 28 28 ASP B 444 SER B 446 5 3 HELIX 29 29 GLN B 447 LYS B 454 1 8 HELIX 30 30 PRO B 465 TRP B 476 1 12 HELIX 31 31 ASN B 479 ARG B 483 5 5 HELIX 32 32 SER B 485 SER B 500 1 16 HELIX 33 33 GLU C 238 THR C 240 5 3 HELIX 34 34 GLY C 249 GLY C 254 1 6 HELIX 35 35 LYS C 263 SER C 265 5 3 HELIX 36 36 GLU C 279 ILE C 293 1 15 HELIX 37 37 ASN C 322 CYS C 330 1 9 HELIX 38 38 ASN C 336 LYS C 357 1 22 HELIX 39 39 ALA C 365 ARG C 367 5 3 HELIX 40 40 GLU C 373 HIS C 375 5 3 HELIX 41 41 PRO C 402 THR C 406 5 5 HELIX 42 42 ALA C 407 ASN C 414 1 8 HELIX 43 43 SER C 417 THR C 434 1 18 HELIX 44 44 ASP C 444 LYS C 454 1 11 HELIX 45 45 PRO C 465 TRP C 476 1 12 HELIX 46 46 ASN C 479 ARG C 483 5 5 HELIX 47 47 SER C 485 PHE C 497 1 13 HELIX 48 48 GLU D 238 ILE D 242 5 5 HELIX 49 49 GLY D 249 GLN D 252 5 4 HELIX 50 50 MET D 278 GLU D 292 1 15 HELIX 51 51 ASN D 322 CYS D 330 1 9 HELIX 52 52 ASN D 336 LYS D 357 1 22 HELIX 53 53 ALA D 365 ARG D 367 5 3 HELIX 54 54 GLU D 373 HIS D 375 5 3 HELIX 55 55 GLY D 383 MET D 388 1 6 HELIX 56 56 PRO D 402 THR D 406 5 5 HELIX 57 57 ALA D 407 ASN D 414 1 8 HELIX 58 58 SER D 417 THR D 434 1 18 HELIX 59 59 ASP D 444 LYS D 454 1 11 HELIX 60 60 PRO D 465 CYS D 475 1 11 HELIX 61 61 SER D 485 GLN D 498 1 14 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O LEU A 266 N TRP A 261 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 3 GLY A 321 ASN A 322 0 SHEET 2 B 3 CYS A 369 VAL A 371 -1 O VAL A 371 N GLY A 321 SHEET 3 B 3 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 THR A 394 HIS A 396 0 SHEET 2 C 2 ALA A 399 PHE A 401 -1 O PHE A 401 N THR A 394 SHEET 1 D 5 ILE B 242 LYS B 247 0 SHEET 2 D 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 D 5 LEU B 266 LEU B 273 -1 O VAL B 270 N TYR B 257 SHEET 4 D 5 PHE B 311 GLU B 316 -1 O THR B 315 N ALA B 269 SHEET 5 D 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 E 2 CYS B 369 VAL B 371 0 SHEET 2 E 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 F 5 ILE C 242 LYS C 247 0 SHEET 2 F 5 VAL C 256 TRP C 261 -1 O GLU C 258 N HIS C 246 SHEET 3 F 5 LEU C 266 LYS C 271 -1 O LEU C 266 N TRP C 261 SHEET 4 F 5 TYR C 312 GLU C 316 -1 O THR C 315 N ALA C 269 SHEET 5 F 5 LEU C 301 CYS C 305 -1 N LEU C 302 O ILE C 314 SHEET 1 G 2 CYS C 369 VAL C 371 0 SHEET 2 G 2 VAL C 377 VAL C 379 -1 O LYS C 378 N LEU C 370 SHEET 1 H 5 THR D 243 LYS D 247 0 SHEET 2 H 5 VAL D 256 VAL D 260 -1 O GLU D 258 N HIS D 246 SHEET 3 H 5 VAL D 268 LEU D 273 -1 O VAL D 268 N GLY D 259 SHEET 4 H 5 PHE D 311 GLU D 316 -1 O THR D 315 N ALA D 269 SHEET 5 H 5 LEU D 301 CYS D 305 -1 N GLY D 303 O ILE D 314 SHEET 1 I 2 CYS D 369 VAL D 371 0 SHEET 2 I 2 VAL D 377 VAL D 379 -1 O LYS D 378 N LEU D 370 SHEET 1 J 2 THR D 394 HIS D 396 0 SHEET 2 J 2 ALA D 399 PHE D 401 -1 O ALA D 399 N HIS D 396 CISPEP 1 PRO A 309 PRO A 310 0 -11.23 CISPEP 2 PRO B 309 PRO B 310 0 4.67 CISPEP 3 PRO C 309 PRO C 310 0 -14.45 CISPEP 4 PRO D 309 PRO D 310 0 18.11 SITE 1 AC1 14 LEU A 248 TYR A 253 ALA A 269 LYS A 271 SITE 2 AC1 14 GLU A 286 MET A 290 ILE A 293 ILE A 313 SITE 3 AC1 14 THR A 315 MET A 318 HIS A 361 ALA A 380 SITE 4 AC1 14 ASP A 381 PHE A 382 SITE 1 AC2 16 TYR B 253 ALA B 269 LYS B 271 GLU B 286 SITE 2 AC2 16 MET B 290 ILE B 293 LEU B 298 ILE B 313 SITE 3 AC2 16 THR B 315 PHE B 317 MET B 318 PHE B 359 SITE 4 AC2 16 HIS B 361 ALA B 380 ASP B 381 PHE B 382 SITE 1 AC3 15 LEU C 248 TYR C 253 ALA C 269 LYS C 271 SITE 2 AC3 15 GLU C 286 MET C 290 LEU C 298 ILE C 313 SITE 3 AC3 15 THR C 315 PHE C 317 MET C 318 HIS C 361 SITE 4 AC3 15 ALA C 380 ASP C 381 PHE C 382 SITE 1 AC4 14 TYR D 253 ALA D 269 LYS D 271 GLU D 286 SITE 2 AC4 14 MET D 290 LEU D 298 THR D 315 PHE D 317 SITE 3 AC4 14 MET D 318 PHE D 359 HIS D 361 ALA D 380 SITE 4 AC4 14 ASP D 381 PHE D 382 CRYST1 93.926 118.088 123.683 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010647 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008468 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008085 0.00000